The company's proprietary technology uses exosomes, which are cell messengers found in biofluids, to detect RNA, DNA, and proteins from their cell of origin, allowing for non-invasive diagnosis of serious diseases. Exosome Diagnostics aims to reduce or eliminate the need for tissue biopsies by commercializing minimally invasive molecular diagnostics in blood and urine, enabling doctors to select optimal therapies for cancer and other diseases. The company has demonstrated high sensitivity and specificity in detecting key genes and gene mutations associated with various cancers.